Nuvation Bio Inc.
Clinical trials sponsored by Nuvation Bio Inc., explained in plain language.
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Targeted drug tested for Hard-to-Treat cancers with specific genetic flaw
Disease control TerminatedThis study tested an oral drug called AB-106 (taletrectinib) for people with advanced solid tumors that had spread and contained a specific genetic change called an NTRK fusion. The goal was to see if the drug could shrink or control these difficult-to-treat cancers. The trial wa…
Phase: PHASE2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC